Clinical Outcomes Of The Presbyopic Laser Treatment Supracor In Hyperopic And Myopic Eyes.

To evaluate and compare refractive and visual outcomes of the presbyopic laser algorithm SUPRACOR using the TENEO Excimer Laser Platform in myopic and hyperopic eyes.

Asian Eye Institute, Manila, Philippines

[40/500]

In this 12M prospective randomized single surgeon study, 60 subjects (36 myopic and 24 hyperopic) were included: the dominant eye targeted for plano was treated using the aspheric ablation profile PROSCAN and the non-dominant eye was treated with a target of -0.50 D using the Supracor. Same nomogram was used for all eyes. Subjects were 48±3.4 years (58.3% female) for the Hyperopic group (MRSE ranged from 0.25 to 2.25 D) and 51.6±3.3 years of age (66.7% female) for the Myopic group (MRSE ranged from -1.75 to -6.88D). Examinations included manifest refraction, monocular and binocular visual acuity at all distances (UDVA, CDVA UIVA, DCIVA, UNVA and DCNVA), PRSIQ and modified TyPEquestionnaires.

At 12M post-surgery, binocular CDVA and UDVA were ≤0.1 logMAR in 100% of both hyperopic and myopic eyes, with no eye losing ≥2 lines. Mean MRSE in hyperopic eyes was 0.15±0.35 D (dominant) and -0.59±0.56 D (non-dominant) vs -0.18±0.25 D and -0.66±0.49D  in myopic eyes. Functional UIVA (≤0.2 logMAR) was achieved in 95.5% of hyperopic vs 100% of myopic eyes, while functional UNVA rates were 63.6% (Hyperopic) vs 75.0% (myopic). The defocus curve reported a depth of focus at a 0.2 logMAR level up -2.0D (hyperopic eyes) and up to 2.5D (myopic eyes). The satisfaction score (0–10 scale) was ≥8 in 90.9% (Far), 77.3% (Intermediate), and 77.3% (Near) of hyperopic eyes vs 91.7%, 86.1%, and 80.6% in myopic eyes. 

SUPRACOR presbyopic treatment was safe and effective in both groups. Both hyperopic and myopic eyes achieved excellent distance and intermediate vision at 12M post-surgery, with high patient satisfaction. Near vision was better in myopic eyes, though functional rates were substantial in both groups.